Bangladesh Measles: 130 Deaths, Thailand Travel Alert

A nationwide measles emergency vaccination drive launched by Bangladesh health authorities on April 5 is now racing to contain an outbreak that has claimed at least 130 child lives in six weeks and infected more than 7,600 suspected cases across 56 districts. The crisis—fueled by vaccination coverage collapsing from 90% in 2020 to 57% in 2025—has triggered emergency funding of 6.04 billion Bangladeshi Taka ($49M) and the mobilization of over 20 million vaccine doses from international partners.

Why This Matters:

• Residents of Thailand with family ties or business in Bangladesh should be aware that standard travel vaccination protocols may not reflect current outbreak zones.

• Regional contagion risk: Measles is one of the world's most contagious diseases; one infected individual can transmit the virus to 15-18 others.

• Vaccine supply chain lessons: The outbreak illustrates how political disruption and funding gaps can collapse immunization programs within 18 months.

The Scale of the Outbreak

Since mid-March, Bangladesh's health ministry has recorded 6,476 suspected measles cases in children aged six months to five years, with 114 reported deaths during that window alone. Of the total fatalities, only 16 have been laboratory-confirmed as measles-related, but public health experts caution that many children die before testing can occur, or in remote areas where diagnostic capacity is absent. Confirmed measles cases among the same age cohort stand at 826.

The outbreak initially erupted on January 4 in a Rohingya refugee camp in Cox's Bazar, then spread rapidly through Northern Bangladesh and into Dhaka, Rajshahi, Chattogram, Mymensingh, and Khulna divisions. By early April, the virus had penetrated 56 of the country's 64 districts, making this one of the most geographically dispersed measles surges in Bangladesh's recent history.

No New Variant Confirmed—Yet

A high-level investigation team assembled by Bangladesh's health ministry is examining whether a novel measles variant is driving the outbreak. The inquiry was prompted by unusual epidemiological patterns: a significant proportion of infected children—34% of cases—are under nine months old, an age group that typically has not yet received the first measles-rubella (MR1) vaccine dose, which is administered at nine months under standard protocols.

Professor Mahmudur Rahman, a leading epidemiologist in the investigation, stated that the high infection rate among infants below the usual vaccination age "requires scientific investigation." However, as of April 6, no new strain has been genetically confirmed. The measles virus remains highly contagious by nature, spreading through coughing, sneezing, and airborne droplets, with symptoms appearing 10 to 12 days after exposure and infectiousness peaking up to four days before the characteristic rash emerges.

How Vaccination Coverage Collapsed

The immediate cause of the outbreak is a dramatic collapse in immunization coverage. Vaccination rates fell from roughly 90% in 2020 to approximately 57% in 2025, according to data from the World Health Organization (WHO) and Bangladesh's health directorate. This decline created what the WHO terms an "immunity gap"—a large, unprotected pediatric population vulnerable to rapid viral spread.

Several factors converged to produce this gap:

Suspended mass campaigns: Bangladesh has not conducted a nationwide measles-rubella vaccination drive since 2020. A follow-up campaign scheduled for June 2024 was canceled due to deadly political unrest that year, leaving millions of children without catch-up doses.

Routine immunization disruptions: Political instability and a funding crunch following the suspension of a sector program that finances vaccination efforts disrupted routine services. Many clinics reported shortages of syringes and vaccine vials, forcing parents to delay or skip appointments.

Geographic inequity: Vaccination coverage varied widely across regions, with Cox's Bazar, Barguna, Chapainawabganj, Pabna, and Natore identified as particularly high-risk districts where routine immunization rates had fallen below 50%.

Invalid doses: Health officials have noted a higher rate of invalid first doses (MR1) due to cold-chain failures and expired stock, further reducing effective coverage.

Emergency Response Mobilizes International Partners

In response to the escalating crisis, Bangladesh's Ministry of Health and Family Welfare launched an emergency measles-rubella vaccination campaign on April 5, targeting over 1.3 million children aged six months to five years across 30 sub-districts in 18 high-risk districts. The campaign will expand in phases to cover the entire country.

Key elements of the response:

The government has lowered the vaccination eligibility age from nine months to six months, reflecting the high proportion of infant cases. Catch-up campaigns are underway for all children up to five years of age, regardless of prior vaccination history.

International collaboration: The emergency drive is supported by UNICEF, the WHO, and Gavi, the Vaccine Alliance. Gavi has supplied over 20 million doses to Bangladesh, with additional shipments requested to cover the expanded target population.

Financial allocation: The government approved 6.04 billion Bangladeshi Taka (approximately $49M) in emergency funding for vaccine procurement from the private market and to expand treatment infrastructure, including intensive care units and ventilator capacity in hard-hit regions like Rajshahi and Manikganj.

Healthcare workforce mobilization: The Directorate General of Health Services has suspended all health worker leave to ensure continuous service delivery during the critical vaccination period.

High-level coordination: Prime Minister Tarique Rahman has directed senior ministers to conduct a nationwide assessment of the crisis and coordinate response efforts across ministries.

What This Means for Residents

For those living in Thailand, the Bangladesh outbreak serves as both a regional health alert and a case study in the fragility of vaccination programs. Measles does not respect borders, and the virus can easily be imported by travelers, especially in densely populated urban centers like Bangkok or tourist hubs such as Phuket and Chiang Mai.

Travel considerations: Anyone with family or business ties in Bangladesh should verify that children are up to date on measles-rubella-mumps (MMR) vaccinations before travel. Standard Thai vaccination schedules administer the first MMR dose at 12 months, but infants as young as six months can receive an early dose if traveling to outbreak zones.

Supply chain lessons: The collapse of Bangladesh's immunization coverage—from 90% to 57% in just five years—demonstrates how quickly political instability and funding disruptions can erode public health infrastructure. Thailand's Ministry of Public Health has maintained high MMR coverage rates above 95%, but the Bangladesh case underscores the need for sustained investment and contingency planning.

Workplace policies: Employers in Thailand with Bangladeshi staff or supply chain operations in the region should consider offering vaccination clinics and updating travel health protocols to reflect current outbreak zones.

Complications and Vulnerability

Measles is not a mild childhood illness. The virus can trigger severe complications, including brain swelling (encephalitis), pneumonia, ear infections, and severe dehydration, all of which can be fatal, particularly in malnourished children. The WHO reports that malnourished children in Bangladesh are at exceptionally high risk for severe disease.

A characteristic brown or red rash typically appears two to four days after initial symptoms—high fever, runny nose, cough, and conjunctivitis—but patients are contagious well before the rash emerges, making containment difficult. Small white spots inside the cheeks (Koplik's spots) are an early diagnostic clue for clinicians.

Path to Herd Immunity

Bangladesh public health officials have set a target of achieving 95% vaccination coverage to establish herd immunity and prevent future outbreaks. The emergency campaign is the first step, but sustained routine immunization and catch-up drives will be necessary to close the immunity gap.

The WHO has advised Bangladesh to reinforce disease surveillance, expedite laboratory confirmation of suspected cases, enhance case management (including vitamin A supplementation, which reduces measles mortality), and improve risk communication to combat vaccine hesitancy and misinformation.

The outbreak's rapid geographic spread—from a single refugee camp in Cox's Bazar to 56 districts in fewer than three months—illustrates the explosive potential of measles in under-vaccinated populations. For regional neighbors, including Thailand, the crisis is a reminder that immunization is not a one-time event but a continuous public health commitment.